Immo Pharma Pas SA
The score of Immo Pharma Pas shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -33 % Total assets -35 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immo Pharma Pas's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | −14,718 € | ||||
| Equity | 192,530 € | ||||
| Cash | 157,493 € | ||||
| EBITDA | −1,387 € | ||||
| Total assets | 204,009 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 02 Sep 2026
- Year ended 31 Mar 2025filed on 06 Oct 2025
- Year ended 31 Mar 2024filed on 17 Jul 2024
- Year ended 31 Mar 2023filed on 26 Sep 2023
- Year ended 31 Mar 2022filed on 22 Sep 2022
Immo Pharma Pas's financial analysis
- Solvency94.4%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Immo Pharma Pas
Immo Pharma Pas's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0443.688.490
- VAT number
- BE0443688490
- Peppol
- Registered · 0208:0443688490 · as of 07 Nov 2026
- Legal form
- SA
- Incorporated
- 26 Mar 1991
- Registered office
- 2460 Kasterlee
- Latest accounts
- 2026 · filed on 02 Sep 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Immo Pharma Pas (SA) has been based in Kasterlee since 1991, active in: business and other management consultancy activities. For 2026, it reports a net loss of 14,718 € and equity of 192,530 €; its revenue is not published. Its solvency stands at 94.4%, above the median of its sector (58.4%).
Companies similar to Immo Pharma Pas
Companies in the same business, of comparable size and area, outside its group.
- Nmtta Business and other management consultancy activities Hoogstraten · balance sheet 370,612 €
- R&D Events Business and other management consultancy activities Lievegem · balance sheet 366,825 €
- B&L Buildconcept Activities of holding companies Bree · balance sheet 492,697 €
- Strik Consulting Business and other management consultancy activities Bonheiden · balance sheet 15,176 €
- PharmaLegal Business and other management consultancy activities Forest · balance sheet €4.90m
- Sogephar Retail sale of pharmaceutical products Ixelles · balance sheet 337,204 €
- Celine Business and other management consultancy activities Mechelen · balance sheet €9.92m
- Tillion - S.S.T. Accounting, bookkeeping and auditing activities; tax consultancy Herent · balance sheet €8.14m
Frequently asked questions about Immo Pharma Pas
What is the revenue of Immo Pharma Pas?
Immo Pharma Pas files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Immo Pharma Pas?
In Belgium, the VAT number is the company number prefixed with BE: BE0443688490 for Immo Pharma Pas, if the company is VAT-registered. Its company number (CBE) is 0443.688.490.
Where is the registered office of Immo Pharma Pas?
According to the CBE register, the registered office of Immo Pharma Pas is in 2460 Kasterlee.
What is the equity of Immo Pharma Pas?
At the close of the 2026 financial year, the equity of Immo Pharma Pas amounts to 192,530 €, a solvency of 94.4% of total assets.
Who manages Immo Pharma Pas?
The register lists 3 active mandates at Immo Pharma Pas. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immo Pharma Pas
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →